Related Experiment Video
Updated: Jun 15, 2025

06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
Head and neck cancer: pathogenesis and targeted therapy
Yan Liu1,2, Nannan Zhang3, Yi Wen4
1Frontiers Medical Center Tianfu Jincheng Laboratory Chengdu China.
Medcomm
|August 22, 2024
Summary
Head and neck cancer (HNC) is aggressive, often diagnosed late and resistant to treatment. This review explores HNC pathogenesis and novel therapeutic strategies, including immunotherapy and targeted therapies, for improved patient outcomes.
Area of Science:
- Oncology
- Cancer Research
- Molecular Biology
Background:
- Head and neck cancer (HNC) is a highly aggressive malignancy.
- Delayed diagnosis, recurrence, metastasis, and drug resistance present significant challenges.
- Risk factors include smoking, alcohol, HPV infection, and genetic/epigenetic predispositions.
Purpose of the Study:
- To review the pathogenesis of head and neck cancer.
- To summarize current and emerging therapeutic strategies for HNC.
- To discuss recent advancements and future research directions.
Main Methods:
- Comprehensive literature review of preclinical and clinical studies.
- Analysis of genetic, epigenetic, signaling pathway, and immune regulation mechanisms in HNC.
- Evaluation of various therapeutic modalities and their clinical trial outcomes.
Main Results:
- HNC pathogenesis involves complex genetic/epigenetic alterations and dysregulated signaling.
- Standard treatments (surgery, radiotherapy, chemotherapy) have limitations, especially for metastatic disease.
- Emerging therapies like targeted therapy, immunotherapy, antibody-drug conjugates, and mRNA vaccines show promise.
Conclusions:
- Understanding HNC pathogenesis is crucial for developing effective treatments.
- Combination therapies and novel treatment modalities offer new hope for managing HNC.
- Continued research into new targets and therapeutic strategies is essential for improving survival rates.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861

